Literature DB >> 23690575

Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.

Tomoyuki Yamaguchi1, Ayumi Kishi, Motonao Osaki, Hiromasa Morikawa, Paz Prieto-Martin, Kajsa Wing, Takashi Saito, Shimon Sakaguchi.   

Abstract

Thymus-produced CD4(+) regulatory T (Treg) cells, which specifically express the transcription factor forkhead box p3, are potently immunosuppressive and characteristically possess a self-reactive T-cell receptor (TCR) repertoire. To determine the molecular basis of Treg suppressive activity and their self-skewed TCR repertoire formation, we attempted to reconstruct these Treg-specific properties in conventional T (Tconv) cells by genetic manipulation. We show that Tconv cells rendered IL-2 deficient and constitutively expressing transgenic cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) were potently suppressive in vitro when they were preactivated by antigenic stimulation. They also suppressed in vivo inflammatory bowel disease and systemic autoimmunity/inflammation produced by Treg deficiency. In addition, in the thymus, transgenic CTLA-4 expression in developing Tconv cells skewed their TCR repertoire toward higher self-reactivity, whereas CTLA-4 deficiency specifically in developing thymic Treg cells cancelled their physiological TCR self-skewing. The extracellular portion of CTLA-4 was sufficient for the suppression and repertoire shifting. It interfered with CD28 signaling to responder Tconv cells via outcompeting CD28 for binding to CD80 and CD86,or modulating CD80/CD86 expression on antigen-presenting cells. Thus, a triad of IL-2 repression, CTLA-4 expression, and antigenic stimulation is a minimalistic requirement for conferring Treg-like suppressive activity on Tconv cells, in accordance with the function of forkhead box p3 to strongly repress IL-2 and maintain CTLA-4 expression in natural Treg cells. Moreover, CTLA-4 expression is a key element for the formation of a self-reactive TCR repertoire in natural Treg cells. These findings can be exploited to control immune responses by targeting IL-2 and CTLA-4 in Treg and Tconv cells.

Entities:  

Keywords:  CD25; immune tolerance; thymic selection

Mesh:

Substances:

Year:  2013        PMID: 23690575      PMCID: PMC3677445          DOI: 10.1073/pnas.1307185110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.

Authors:  Z X Zhang; L Yang; K J Young; B DuTemple; L Zhang
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

3.  CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.

Authors:  John J Engelhardt; Timothy J Sullivan; James P Allison
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

4.  Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.

Authors:  Cecilia Oderup; Lukas Cederbom; Anna Makowska; Corrado M Cilio; Fredrik Ivars
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

5.  CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2.

Authors:  Tomohisa Okamura; Keishi Fujio; Mihoko Shibuya; Shuji Sumitomo; Hirofumi Shoda; Shimon Sakaguchi; Kazuhiko Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

6.  CTLA-4-Ig regulates tryptophan catabolism in vivo.

Authors:  Ursula Grohmann; Ciriana Orabona; Francesca Fallarino; Carmine Vacca; Filippo Calcinaro; Alberto Falorni; Paola Candeloro; Maria L Belladonna; Roberta Bianchi; Maria C Fioretti; Paolo Puccetti
Journal:  Nat Immunol       Date:  2002-09-30       Impact factor: 25.606

Review 7.  A molecular perspective of CTLA-4 function.

Authors:  Wendy A Teft; Mark G Kirchhof; Joaquín Madrenas
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

8.  Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.

Authors:  Afonso R M Almeida; Nicolas Legrand; Martine Papiernik; António A Freitas
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

Review 9.  Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

10.  Intraclonal competition limits the fate determination of regulatory T cells in the thymus.

Authors:  Jhoanne L Bautista; Chan-Wang J Lio; Stephanie K Lathrop; Katherine Forbush; Yuqiong Liang; Jingqin Luo; Alexander Y Rudensky; Chyi-Song Hsieh
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

View more
  37 in total

Review 1.  Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

Authors:  Mark A Perazella; Anushree C Shirali
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

2.  Peripherally Induced Tolerance Depends on Peripheral Regulatory T Cells That Require Hopx To Inhibit Intrinsic IL-2 Expression.

Authors:  Andrew Jones; Adeleye Opejin; Jacob G Henderson; Cindy Gross; Rajan Jain; Jonathan A Epstein; Richard A Flavell; Daniel Hawiger
Journal:  J Immunol       Date:  2015-07-13       Impact factor: 5.422

Review 3.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

4.  Adipose Tissue T Regulatory Cells: Implications for Health and Disease.

Authors:  David Bradley; Dharti Shantaram; Alan Smith; Willa A Hsueh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Hand transplants and the mandate for tolerance.

Authors:  Maria Koulmanda; Bohdan Pomahac; Zhigang Fan; George F Murphy; Terry B Strom
Journal:  Curr Opin Organ Transplant       Date:  2014-12       Impact factor: 2.640

Review 6.  Regulatory T cells in cancer immunotherapy.

Authors:  Atsushi Tanaka; Shimon Sakaguchi
Journal:  Cell Res       Date:  2016-12-20       Impact factor: 25.617

7.  Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.

Authors:  A Picchianti Diamanti; M M Rosado; M Scarsella; V Germano; E Giorda; S Cascioli; B Laganà; R D'Amelio; R Carsetti
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 8.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

9.  Humanized mice as a model for aberrant responses in human T cell immunotherapy.

Authors:  Nalini K Vudattu; Frank Waldron-Lynch; Lucy A Truman; Songyan Deng; Paula Preston-Hurlburt; Richard Torres; Maurice T Raycroft; Mark J Mamula; Kevan C Herold
Journal:  J Immunol       Date:  2014-06-18       Impact factor: 5.422

10.  Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.

Authors:  Takuro Saito; Hiroyoshi Nishikawa; Hisashi Wada; Yuji Nagano; Daisuke Sugiyama; Koji Atarashi; Yuka Maeda; Masahide Hamaguchi; Naganari Ohkura; Eiichi Sato; Hirotsugu Nagase; Junichi Nishimura; Hirofumi Yamamoto; Shuji Takiguchi; Takeshi Tanoue; Wataru Suda; Hidetoshi Morita; Masahira Hattori; Kenya Honda; Masaki Mori; Yuichiro Doki; Shimon Sakaguchi
Journal:  Nat Med       Date:  2016-04-25       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.